Spiral Therapeutics Announces Poster Presentation at Association for Research in Otolaryngology Annual Meeting
SOUTH SAN FRANCISCO, Calif., Feb. 06, 2023 — Spiral Therapeutics, Inc. (“Spiral”), a clinical-stage company delivering therapies for inner ear disorders, today announced a presentation at the upcoming Association for Research in Otolaryngology (ARO) 46th Annual MidWinter Meeting, to be held February 11-15, 2023 in Orlando, FL. Dr. Isabel Varela-Nieto will present a poster related […]
Spiral Therapeutics Completes $8.25M Financing and Initiates Phase 2 Trial in Ménière’s Disease
SOUTH SAN FRANCISCO, Calif., Jan. 09, 2023 — Spiral Therapeutics, Inc. (“Spiral”), a clinical-stage company focused on delivering therapies for inner ear disorders, today announced that the Company recently completed an $8.25M financing, with new proceeds that will fund the continuing development of its lead candidate, SPT-2101, for the treatment of inner ear inflammation. Existing […]
Spiral Therapeutics to Present at Biotech Showcase 2023
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 — Spiral Therapeutics, Inc. (“Spiral”), a clinical-stage company delivering therapies for inner ear disorders, today announced that the Company will provide a corporate overview at Biotech Showcase 2023 taking place in San Francisco, California, from January 9-11, 2023. Presenter Hugo Peris, Chief Executive Officer and President of Spiral […]